Hence, we examined the expressions of HDAC1, HDAC2, HDAC3, HDAC4, and HDAC5 and an inflammation marker (VCAM-1) in these two cell types following ALS treatment. The gene discussed is HDAC4; the disease is amyotrophic lateral sclerosis.